Company / Inventory
ACCENDRA HEALTH INC/VA/ Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$74.4M
FY2025
5-year range
$67.6M / $1.5B
FY2021-FY2025
Trend
+10.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Inventory returned to growth in FY2025 after 3 years of decline, reaching $74M.
Based on SEC 10-K filings.
$74M in FY2025 with a 5-year CAGR of -43.0%.
Declined from $1.1B to $74M over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- -61.8%
- 5-Year CAGR
- -43.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -43.0%, indicating a declining trend.
- In FY2025, inventory increased 10.1% year-over-year.
- Peak inventory was recorded in FY2021.
- Lowest inventory in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $74.4M | +10.1% |
| FY2024 | $67.6M | -93.9% |
| FY2023 | $1.1B | -16.7% |
| FY2022 | $1.3B | -10.9% |
| FY2021 | $1.5B | +21.3% |
| FY2020 | $1.2B | +7.6% |
| FY2019 | $1.1B | -10.0% |
| FY2018 | $1.3B | +28.6% |
| FY2017 | $990.2M | +8.1% |
| FY2016 | $916.3M | -2.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026